Consistently Estimating Absolute Risk Difference when Translating Evidence to Jurisdictions of Interest

Author： Eckermann Simon  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.2, 2011-02, pp. : 87-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translating “Best Interest”: Child Welfare Decisions at the US–México Border

By  

POLAR: POLITICAL AND LEGAL ANTHROPOLOGY REVIEW, Vol. 39, Iss. S1, 2016-09 ,pp. : 154-168

John Wiley & Sons Inc

Access to resources Recommend Favorite

Absolute MI risk a basis for treatment decisions in diabetes

By  

Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A model for translating evidence into clinical practice?

By  

Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Pitfalls in estimating drug-related crash risk

By Ramaekers J.G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 3, 2003-03 ,pp. : 114-115

Elsevier

Access to resources Recommend Favorite

Combining Risk Difference and Risk Ratio in Noninferiority Trials of Safety

By Broglio Kristine R.   Connor Jason T.   Berry Scott M.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 261-271

Taylor & Francis Ltd

Access to resources Recommend Favorite